bmy 21502 has been researched along with Alzheimer Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutler, NR; Hironaka, DY; Reich, LA; Seifert, RD; Shrotriya, RC; Sramek, JJ; Veroff, AE | 1 |
| Cutler, NR; Hironaka, DY; Shrotriya, RC; Sramek, JJ; Veroff, AE | 1 |
| Coffin, JM; Haunton-Kreps, M; Moon, SL; Sasse, DK; Woodruff-Pak, DS | 1 |
2 trial(s) available for bmy 21502 and Alzheimer Disease
| Article | Year |
|---|---|
The use of the Computerized Neuropsychological Test Battery (CNTB) in an efficacy and safety trial of BMY 21,502 in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Placebos; Psychotropic Drugs; Pyrimidines; Pyrrolidinones | 1993 |
Efficacy and safety of BMY 21,502 in Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychotropic Drugs; Pyrimidines; Pyrrolidinones | 1996 |
1 other study(ies) available for bmy 21502 and Alzheimer Disease
| Article | Year |
|---|---|
Effect of BMY 21502 on classical conditioning of the eyeblink response in young and older rabbits.
Topics: Aging; Alzheimer Disease; Animals; Blinking; Conditioning, Classical; Female; Male; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrimidines; Pyrrolidinones; Rabbits | 1991 |